Emil D. Kakkis - President & CEO, Director at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

Emil D. Kakkis - trading volume in the past year for Ultragenyx Pharmaceutical Inc.

Holdings reported by Emil D. Kakkis for Ultragenyx Pharmaceutical Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2.18M $92.2M $42.23 Dec 30, 2024 By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009
Common Stock 565K $23.8M $42.23 Dec 30, 2024 Direct
Stock Option (Right to Buy) 70.1K Mar 1, 2024 Direct Common Stock

Transactions reported by Emil D. Kakkis for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.